相关实验视频

Updated: Jul 2, 2025

Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing

Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing

Published on: January 11, 2013

在狗中中枢修复后的低血糖症

Yasuyuki Nii^1,2, Emi Takahashi^1,3, Miho Tabata³

¹JASMINE Veterinary Cardiovascular Medical Center, Yokohama 224-0001, Japan.

Veterinary sciences

|February 23, 2024

概括

低血糖症是一种低血糖并发症,在米特拉修复 (MVR) 后影响14.2%的狗. 低体重和肌肉膜病是关键的危险因素. 在MVR后监测血糖非常重要.

科学领域:

兽医医学兽医医学兽医医学
心脏病学心脏病学
内分泌学在内分泌学.

背景情况:

低血糖是未被识别的术后并发症,在接受关节修复 (MVR) 的狗中出现.
了解其发生率和原因对于患者护理至关重要.

研究的目的:

为了确定MVR后狗中低血糖的发生率.
为了调查手术后低血糖症的潜在原因.
为了确定与MVR后低血糖相关的危险因素.

主要方法:

一项前性研究,测量在MVR之前和之后的狗血糖,胰岛素和葡萄糖水平.
风险因素的分析,包括体重和中枢门疾病状态.

主要成果:

在MVR后低血糖的发生率为14.2%.
患有低血糖症的狗表现出葡萄糖的增加和胰岛素水平的降低,排除了超胰岛素症或低血糖症作为原因.
低体重和无症状的肌肉性关膜疾病被确定为显著的危险因素.

结论:

手术后低血糖是狗中MVR的一个显著并发症.
常规血糖监测应纳入MVR后住院治疗方案.
早期识别有风险的患者可以预防严重的低血糖事件.

关键词:

在CPB中,CPB是CPB.这是一个MMVDVD.狗类犬类动物狗类犬类葡萄糖是一种葡萄糖.葡萄糖葡萄糖葡萄糖葡萄糖在这种情况下,胰岛素胰岛素胰岛素.在手术后出现低血糖症

更多相关视频

Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery

Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery

Published on: August 16, 2019

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

相关概念视频

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...